XXII
(NYSE)
0.7521
+0.0105  (+1.40%)
Volume (24h): 585.68K Day Range: 0.7087 - 0.7899
Market Cap: 104.43M 52W Range: 0.6000 - 2.46
Mar-23-20 01:08PM Does The 22nd Century Group, Inc. (NYSEMKT:XXII) Share Price Fall With The Market?Simply Wall St.
Mar-12-20 10:50AM 22nd Century Group, Inc. Files 2019 Annual ReportBusiness Wire
Mar-11-20 08:15PM 22nd Century Announces Important New Achievements with KeyGeneGlobeNewswire
Mar-10-20 08:15PM 22nd Century Group Adds to Leadership TeamGlobeNewswire
Mar-04-20 06:04PM CORRECTION: Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use of Very Low Nicotine Content Cigarettes Does Not Lead to Compensatory SmokingGlobeNewswire
11:50AM Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm UseGlobeNewswire
Feb-18-20 12:00PM FDA Scientific Advisory Committee Discusses 22nd Century Group’s Reduced Nicotine CigarettesBusiness Wire
Feb-11-20 06:30PM 22nd Century Group’s FDA Advisory Committee Meeting for Reduced Nicotine Content Cigarettes Brings New Standard for the Tobacco IndustryBusiness Wire
Jan-22-20 06:25PM If You Had Bought 22nd Century Group (NYSEMKT:XXII) Stock A Year Ago, You'd Be Sitting On A 50% Loss, TodaySimply Wall St.
Jan-13-20 11:45AM 22nd Century Group Appoints New Director and New ChairmanGlobeNewswire
Dec-23-19 08:39PM 22nd Century Group to Present its Modified Risk Tobacco Product Application to FDA’s Tobacco Products Scientific Advisory CommitteeGlobeNewswire
Dec-17-19 06:34PM FDA Authorizes Marketing of 22nd Century Group’s Proprietary Moonlight® and Moonlight® Menthol CigarettesGlobeNewswire
Dec-13-19 09:03PM 22nd Century Group Announces Management ChangesGlobeNewswire
Dec-05-19 06:06PM 22nd Century Enters CBD Space With $24M Investment In PanaceaBenzinga
Dec-03-19 11:09PM Shareholder Alert: Robbins LLP Reminds Investors 22nd Century Group, Inc. (XXII) Sued for Misleading ShareholdersBusiness Wire
10:24PM 22nd Century Group Enters CBD Health and Wellness Market with Investment in Panacea Life Sciences, Inc.GlobeNewswire
Nov-27-19 05:09AM Edited Transcript of XXII earnings conference call or presentation 8-Nov-19 2:00pm GMTThomson Reuters StreetEvents
Nov-26-19 11:49PM Edited Transcript of XXII earnings conference call or presentation 8-Nov-19 2:00pm GMTThomson Reuters StreetEvents
Nov-21-19 01:51PM 22nd Century Group Comments on Delay of Reduced Nicotine Rule for CigarettesGlobeNewswire
Nov-10-19 04:52PM Edited Transcript of XXII earnings conference call or presentation 8-Nov-19 2:00pm GMTThomson Reuters StreetEvents
Nov-07-19 09:30PM 22nd Century Group Files 2019 Third Quarter ReportBusiness Wire
Nov-04-19 09:06PM 22nd Century Group Announces Webcast to Provide Business UpdateGlobeNewswire
Oct-10-19 07:50PM Does 22nd Century Group (NYSEMKT:XXII) Have A Healthy Balance Sheet?Simply Wall St.
Sep-12-19 11:28AM Trump May Ban Flavored E-Cigarettes: Who Wins, Who LosesZacks
Sep-06-19 11:51AM 3 Pot Stocks to Avoid Like the Plague in SeptemberMotley Fool
Sep-03-19 11:21AM Only These 10 Pot Stocks Ended August HigherMotley Fool
Aug-31-19 11:30AM 3 Best Marijuana Stocks of August -- Are They Buys Now?Motley Fool
Aug-28-19 10:15PM 22nd Century Group Inc (XXII) President and CEO Clifford B Fleet Bought $190,000 of SharesGuruFocus.com
Aug-26-19 09:40AM Will 22nd Century Group Continue to Surge Higher?Zacks
Aug-23-19 02:02PM 22nd Century Group, Inc. (NYSEMKT:XXII): What Does Its Beta Value Mean For Your Portfolio?Simply Wall St.
Aug-16-19 07:27AM Edited Transcript of XXII earnings conference call or presentation 8-Aug-19 8:00pm GMTThomson Reuters StreetEvents
Aug-09-19 11:03PM 22nd Century Group Inc (XXII) Q2 2019 Earnings Call TranscriptMotley Fool
Aug-07-19 08:15PM 22nd Century Group Files 2019 Second Quarter ReportBusiness Wire
Aug-01-19 01:05PM The LD Micro Index Turns Four Years OldACCESSWIRE
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)